Status:
COMPLETED
Standard Patient Training Versus Vik Chatbot Guided Training: a Randomized Controlled Trial for Asthma Patients
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The onset of smartphone usage has provided new opportunities for managing patients outside the walls of healthcare facilities. The development of asthma-specific smartphone applications represents an ...
Detailed Description
Secondarily, the following will also be compared between the two study arms: * the subdomains of the AQLQ score, * lung function, overall asthma control and exacerbation rates, * general health statu...
Eligibility Criteria
Inclusion
- Minimum age: 18
- Physician-confirmed diagnosis of asthma
Exclusion
- Protected populations according to the French Public Health Code Articles L1121-6,8
- The subject has already participated in the present study
- Subject unable to comply with trial procedures/visits
- Potential for interference from another study
- Non-beneficiary of the French single-payer national medical insurance system
- Lack of informed consent
- Patients already using the Vik Asthma application in their daily lives or having already followed a therapeutic education program
Key Trial Info
Start Date :
May 24 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 27 2023
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT05248126
Start Date
May 24 2022
End Date
October 27 2023
Last Update
January 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Montpellier
Montpellier, France, 34295